Last reviewed · How we verify

NCT06142409

Effect of Enzyme-containing Lozenge on Dental Biofilm Formation, Composition and Functionality

Completed NA Last updated 3 January 2025
What this trial tests

NA trial testing Enzyme containing lozenge in Dental Biofilm Accumulation in 34 participants. Completed in 25 February 2024.

Timeline
17 August 2023
Primary endpoint
25 February 2024
25 February 2024

Quick facts

Lead sponsorNovozymes A/S
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposesupportive care
Enrollment34
Start date17 August 2023
Primary completion25 February 2024
Estimated completion25 February 2024
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Novozymes A/S

Who can join

18 and older, any sex, with Dental Biofilm Accumulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A double-blind, placebo-controlled randomized cross-over trial evaluating the effect of enzyme-containing lozenge on in vivo and in situ grown dental biofilm accumulation. The study includes two phases, one each for the investigation of in-vivo and in-situ grown dental biofilm

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Enzyme containing lozenge

Trials testing the same drug.

Other Novozymes A/S trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06142409.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing